Johnson & Johnson boosted its profit forecast for the year on Tuesday after posting better-than-expected quarterly earnings on stronger prescription sales of its psoriasis treatment Stelara and cancer drug Imbruvica.
Source:: Breaking News
Prescription drugs boost drives J&J forecasts higher, shares rise
More from Latest StoryMore posts in Latest Story »
- Collagen Chai Tea for Glowing Skin with Turmeric and Ginger
- Collagen Chai Tea for Glowing Skin with Turmeric and Ginger
- ‘I’m Not Doing This for Money’: Nelly Hits Back Following Backlash Over His Scheduled Performance at Donald Trump’s Controversial Inaugural Celebration
- ‘He Scared the F–k Out of Me’: Black Homeowner Told By White Neighbor ‘I Don’t Believe That’ After Asking from His Porch If He Lives There, Then She Runs, Screams for Help
- Russian hackers target WhatsApp accounts of ministers worldwide
Be First to Comment